New Drugs

FDA Approves Pizensy (lactitol) for the Treatment of Chronic Idiopathic Constipation in Adults

Written by David Miller

Braintree, Mass. March 02, 2020 — Sebela Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Pizensy (lactitol) for oral solution for the once-daily treatment of chronic idiopathic constipation (CIC)…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]